Vimarsana
Biggest News Aggregation in the World

Page 11 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

RNA sequencing analysis feasible for diagnosis of molecular subtypes in pediatric B-ALL - Vimarsana News

RNA sequencing analysis feasible for diagnosis of molecular subtypes in pediatric B-ALL

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases.

Nearly one in three Americans have no religious affiliation: Who are the 'nones'? | Explained News - Vimarsana News

Nearly one in three Americans have no religious affiliation: Who are the 'nones'? | Explained News

As recently as the early 1990s, about 90% of US adults identified as Christians. What are the reasons people are now less likely to hold the same beliefs as earlier generations? And who exactly make up the non-religious group?

South Korea Diagnostic Labs Market to See Remarkable Growth - Vimarsana News

South Korea Diagnostic Labs Market to See Remarkable Growth

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application - Vimarsana News

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

Global Allergy Diagnostics and Therapeutics Market Expected - Vimarsana News

Global Allergy Diagnostics and Therapeutics Market Expected

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The